Chemical IGF-I composition for the treatment and prevention of neurodegenerative diseases

Details for Australian Patent Application No. 2003209777 (hide)

Owner Consejo Superior De Investigaciones Cientificas Universidad Complutense de Madrid

Inventors Lopez Lopez, Cristina; Torres Aleman, Ignacio; Carro Diaz, Eva Maria; Torrado Duran, Santiago; Torrado Duran, Juan Jose; Carrascosa, Celia

Agent Callinan

Pub. Number AU-B-2003209777

PCT Number PCT/ES03/00087

PCT Pub. Number WO2003/077940

Priority P 200200491 28.02.02 ES

Filing date 21 February 2003

Wipo publication date 29 September 2003

Acceptance publication date 10 January 2008

International Classifications

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 9/58 (2006.01) Medicinal preparations characterised by special physical form

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/30 (2006.01) Medicinal preparations containing peptides - Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): P 200200491 28.02.02 ES

6 November 2003 Application Open to Public Inspection

  Published as AU-B-2003209777

10 January 2008 Application Accepted

  Published as AU-B-2003209777

8 May 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003209778-CILINDRO PARA CERRADURA Y LLAVE PARA EL MISMO

2003209776-TISSUE-TYPE PLASMINOGEN ACTIVATOR (T-PA) INHIBITORS WITH A THERAPEUTIC CAPACITY